What they were paid
Sionna Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $59,800 | $239,839 | $0 | $0 | $299,639 |
| FY2024 | $5,217 | $0 | $333,784 | $0 | $339,001 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sionna Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001628280-26-027489, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Sionna Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation · Nominating/Governance
The rest of the Sionna Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Bruce Booth, D.Phil | Independent Director | $281,239 |
| H. Edward Fleming Jr., M.D | Independent Director | $283,039 |
| Joanne Louise Viney, Ph.D | Independent Director | $810,316 |
| Joshua Resnick, M.D., M.B.A | Independent Director | $275,839 |
| Lucian Iancovici, M.D | Independent Director | $0 |
| Marcella Kuhlman Ruddy, M.D | Independent Director | $803,566 |
| Michael Cloonan, M.B.A | Director | $0 |
| Paul Clancy, M.B.A | Independent Director | $323,139 |
| Peter A. Thompson, M.D | Independent Director | $279,889 |
The full Sionna Therapeutics compensation record
free company briefThis page is one director within Sionna Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat